Trademarkia Logo

United Kingdom

£
Trademark Search
ONCOLYTIC IMMUNOTHERAPY

View On IPO.GOV.UK

Withdrawn

on 13 Sept 2024

Last Applicant/ Owned by

CG Oncology, Inc.

400 Spectrum Center Dr., Suite 2040

Irvine, California, 92618

Serial Number

UK00004099604 filed on 13th Sept 2024

Correspondent Information

Hogan Lovells International LLP

Atlantic House, 50 Holborn Viaduct

London,

EC1A 2FG

ONCOLYTIC IMMUNOTHERAPY

pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunolog Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing.

Class [42]
Computer & Software Services & Scientific Services

Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders.

Mark Details

Serial Number

UK00004099604

Mark Type

Word

Kind of mark

Individual